Table 1. Correlation between MTM expression and clinicopathological features in gastric cancer.
| Clinicopathological features | No. of patients (N=92) | MTM expression evaluated by qRT-PCR | P value |
|---|---|---|---|
| Age | 0.068 | ||
| <60 | 37 | 0.0041 | |
| ≥60 | 55 | 0.0039 | |
| Gender | 0.487 | ||
| Male | 64 | 0.0038 | |
| Female | 28 | 0.0042 | |
| Tumor size | 0.113 | ||
| <5cm | 44 | 0.0049 | |
| ≥5cm | 48 | 0.0031 | |
| Differentiation | 0.190 | ||
| Poor | 57 | 0.0031 | |
| Moderate/High | 35 | 0.0054 | |
| Distant metastasis | 0.313 | ||
| M0 | 85 | 0.0042 | |
| M1 | 7 | 0.0017 | |
| Lymphatic metastasis | 0.003** | ||
| No | 36 | 0.0061 | |
| Yes | 56 | 0.0026 | |
| Invasive depth | 0.016* | ||
| T1 | 18 | 0.0061 | |
| T2 | 12 | 0.0075 | |
| T3 | 7 | 0.0015 | |
| T4 | 55 | 0.0028 | |
| Stage (TNM) | 0.011* | ||
| I | 24 | 0.0076 | |
| II | 15 | 0.0028 | |
| III | 46 | 0.0028 | |
| IV | 7 | 0.0017 |
The results are expressed as the mean of 2-ΔCT. *P<0.05; **P<0.01.